Physician Medical Marijuana CME
$179.00
Target Audience
This activity has been designed to meet the educational needs of physicians involved in the care of patients who are considering using medical marijuana as part of their care plan in States that recognize marijuana as a medical treatment.
Program Agenda
- Module 1: History and Legal Landscape
- Module 2: The Discovery of the Endocannabinoid System
- Module 3: The Endocannabinoid System
- Module 4: Cannabinoids and Terpenes
- Module 5: Studies on Therapeutic Uses
- Module 6: Cannabis and Opioids in Chronic Pain Treatment
- Module 7: Side Effects and Chronic Effects
Course is available online from July 2020 through July 2021
Estimated time to complete activity: 10 hours
If you are a medical group or network and need multi-seat pricing, please call 844.411.0500 x814
Program Overview
The activity is an educational overview of medical cannabis in its current legal context in the US. Currently there are 2.1 million registered medical marijuana patients and there are an estimated 3.5 million patients using medical marijuana nationwide. The constantly changing legal environment in which cannabis can be used in the United States has resulted in confusion for both physicians and patients. Currently, 33 states have legalized medical marijuana and 10 states have also legalized recreational marijuana. Due to the lack of knowledge of the legality of discussing medical marijuana, physicians, nurses and pharmacists are hesitant to discuss with their patients. The lack of communication between the patient and physician can lead to the patient self-medicating with no guidance from a medical professional.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and Medical Marijuana 411. SynAptiv is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
SynAptiv designates this enduring material for a maximum of 10 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Course is available online from July 2020 through July 2021
Estimated time to complete activity: 10 hours
If you are a medical group or network and need multi-seat pricing, please call 844.411.0500 x814
Disclosure Statement
SynAptiv ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, planners, content managers, and other individuals who are in a position to control the content of an activity.
The following faculty, planner and/or content manager reported the following financial relationship with commercial interests whose products or services may be mentioned in this CE activity:Royalty/Patent Holder for Medical Cannabis Textbooks Consulting Fees: Callitas Therapeutics
After completing this activity, the participant should be better able to:
- Interpret the legal context in which cannabis can be discussed with a patient and how states can have legalized medical marijuana even though it is recognized as a federally illegal substance.
- Compare and relate the historical medicinal uses of marijuana to modern resurgence in patient use of medical marijuana.
- Explain why there is a lack of clinical studies due to Schedule I classification of marijuana.
- Summarize and explain the discovery of the Endocannabinoid System and how its discovery has led to further research into how cannabinoids interact with the receptors.
- Summarize the function of the Endocannabinoid System in the regulation of the body through a vast network of receptors involved in maintaining homeostasis, neuroprotection, and other regulatory functions.
- Discuss and interpret how cannabinoids and terpenes affect the Endocannabinoid receptor system.
- Assess pros and cons of cannabinoids and their effects on the symptoms of ailments such as anxiety, chronic pain, epilepsy, gastrointestinal disorders, neurodegenerative illnesses, post-traumatic stress and migraines.
- Evaluate the current research studies regarding opioids versus cannabinoids in the treatment of the symptoms of chronic pain.
- Discuss side effects and contraindications of medicinal cannabis and safety concerns with its use.
- Identify signs of abuse, misuse and chronic effects of marijuana use.
- 10 AMA PRA Category 1 Credits™
- Instant access to all course materials
- Printable and downloadable infographics
- All research materials used for the online course
- Lifetime, unlimited access
- 24/7 access
- No time limits
- Start anytime
- Work on your own time and at your own pace
- Affordably priced
Dr. Gregory Smith has been in primary care practice for over 30 years. He is board certified in Preventive Medicine and obtained his MPH from Harvard University. He first trained on the use of medical cannabis in 2000 in California. He has written extensively on the subject, including his popular textbook, “Medical Cannabis: Basic Science and Clinical Applications” published in 2016, and more recently “Cannabidiol, CBD: What you need to know.” And most recently in 2019, “THCV: Appetite Killer.”
Dr. Kevin Smith has also been in primary care practice for over 30 years. He is board certified in Preventive Medicine and obtained his MPH from Yale University. He trained on the use of medical Cannabis several years ago and has been very active in educating physicians and other medical professionals.
Disclosure Statement
SynAptiv ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, planners, content managers, and other individuals who are in a position to control the content of an activity.
The following faculty, planner and/or content manager reported the following financial relationship with commercial interests whose products or services may be mentioned in this CE activity:Royalty/Patent Holder for Medical Cannabis Textbooks Consulting Fees: Callitas Therapeutics
Comments
39 reviews for Physician Medical Marijuana CME
Add a review
You must be logged in to post a comment.
It was great!
I would add a section on dosing, drug interactions.
Really liked it; great overview in all of the areas; great research citations. Interactive video and more pictures would be useful to us visual learners.
Need more interative opportunities and problem solving, active learning and thinking strategies
excellent, a little heady on the biochemistry and molecular biology but overall a great activity.
OCCASIONAL VIDEO CLIP
More lectures rather than reading material.
would like more detail on specific studies – strains for different cancers, studies in Israel. Would like information on dosing.
Audio would enhance the learning experience for me.
great program overall
Well-organized, easy to understand, clinically applicable intro course into medical marijuana.
Great information, no improvements needed
its perfect
My best assessment is that this course and others to come will be improved as research is supported and more information comes to light and is verified. Each section in this course made me hungry for more factual data to access and incorporate.
very well done!
overall good, update some of the data (use 2019 rather than 2017 data)
More information on hybrids and which hybrids are best to treat which conditions
Perhaps include some video of physicians who have had particularly positive experiences in apply medical marijuana or clinical pearls
it really is a well organized approach.. I don’t think you have much room to improve, maybe more handouts that are printable
This is a great course
My ability to explain to mechanism of ECS has improved greatly which will help me speak more knowledgeably to my patients
Good basic information
More clinical relevance rather than focusing on year figures and percentages.
In the section on cannabis and anxiety, I believe that there is an erroneous reference to seasonal affective disorder (SAD) that is actually supposed to be social phobia patients.
I think that most improvements will come with further research
No further suggestions. Update as info comes.
include more research and studies on marijuana
Excellent learning activity. I’ll be rereading this frequently.
Very good over view. simulated cases with interactive decision making would improve the clinical experience
I learned quite a lot.
more specific information on strength of current evidence in regard to use in each disease state as well as information on available formulations
More exams over smaller amounts of content
Very suitable course for gaining basic knowledge of MMJ and fulfill CME requirements. Thank you.
This activity has been presented very well
more data on top 10 canabinoid subtypes and utility and ratios in MM dispensary, and how thc activates/potentiates cbd
Technological glitches, mediocre presentation of information. This course needs to be upgraded to provide value of $179. Pretty disappointed….
Continue to update study findings
Very well put together. Great information and I plan on integrating it into my practice.
This was an extremely long evaluation – the longest I’ve taken
There were a lot of spelling errors and there were mixed messages in a number of places. I recommend having an editor go over it with a fine tooth comb for word order, spelling errors, etc. Re content, I think in the sections on abuse potential there was a bit of a bias to emphasize negative experiences more than is clinically noted (as a cannabis provider in 3 states and in Israel